Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Mesylate”

630 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 630 results

Large-scale testing (Phase 3)UnknownNCT02576080
What this trial is testing

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

Who this might be right for
Gastrointestinal Stromal Tumor
Assistance Publique Hopitaux De Marseille 80
Not applicableUnknownNCT05895942
What this trial is testing

Exploring the Molecular Mechanism Based on KIT Mutation

Who this might be right for
GIST
Xijing Hospital 190
Very early researchUnknownNCT03228303
What this trial is testing

Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Assiut University 100
Post-approval studies (Phase 4)UnknownNCT04677439
What this trial is testing

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Who this might be right for
FlumatinibChronic Myeloid Leukemia, Chronic PhaseImatinib
Shenzhen Second People's Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00861471
What this trial is testing

Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 24
Not applicableStudy completedNCT00538109
What this trial is testing

An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Who this might be right for
Leukemia, Myeloid, Chronic
King Faisal Specialist Hospital & Research Center 8
Testing effectiveness (Phase 2)Study completedNCT00049192
What this trial is testing

Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous LeukemiaRelapsing Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 43
Not applicableUnknownNCT02034656
What this trial is testing

Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

Who this might be right for
Chronic Myeloid Leukemia or Ph Positive ALL
Seoul St. Mary's Hospital 125
Testing effectiveness (Phase 2)Study completedNCT00338728
What this trial is testing

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveKIT Positive+4 more
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00506831
What this trial is testing

Imatinib in Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Stanford University 9
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Not applicableStudy completedNCT00947830
What this trial is testing

Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Brian Leber 81
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01153750
What this trial is testing

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

Who this might be right for
Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct
University Hospital Dresden 44
Post-approval studies (Phase 4)Study completedNCT01578213
What this trial is testing

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

Who this might be right for
Chronic Myeloid Leukemia
University of Milano Bicocca 112
Not applicableUnknownNCT04136015
What this trial is testing

Early Conversion of Dasatinib in CML-CP Patients

Who this might be right for
Validity and Safety
Nanfang Hospital, Southern Medical University 200
Early research (Phase 1)Study completedNCT00354068
What this trial is testing

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 65
Testing effectiveness (Phase 2)Study completedNCT00161213
What this trial is testing

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Medicine and Dentistry of New Jersey 44
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Early research (Phase 1)Study completedNCT01751919
What this trial is testing

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Dong-A ST Co., Ltd. 37
Next Page